The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.

Pharmaceutical firm Eli Lilly participated in a $56.1m series B round for Strateos, a US-based operator of remotely controlled laboratory facilities, on Tuesday. The round was co-led by venture capital firms DCVC and Lux Capital and included Ally Bridge Group, Black Diamond Ventures, Mack & Co and Castor Ventures. Strateos has built two automated laboratory…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.